Accuray Incorporated (ARAY)
| Market Cap | 377.77M |
| Revenue (ttm) | 380.33M |
| Net Income (ttm) | 4.63M |
| Shares Out | 93.12M |
| EPS (ttm) | 0.05 |
| PE Ratio | 83.80 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 23 |
| Last Price | $4.19 |
| Previous Close | $4.16 |
| Change ($) | 0.03 |
| Change (%) | 0.72% |
| Day's Open | 4.15 |
| Day's Range | 4.13 - 4.21 |
| Day's Volume | 221,481 |
| 52-Week Range | 2.17 - 6.02 |
SUNNYVALE, Calif., July 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at Hong Kong Sanatorium & Hospital (HKSH) in Hong Kong treated the first c...
SUNNYVALE, Calif., July 14, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2021, ended June 30, 2021, after the market clos...
SUNNYVALE, Calif., June 24, 2021 /PRNewswire/ -- The University of Wisconsin-Madison (UW-Madison) School of Veterinary Medicine team is advancing cancer care as the first to treat an animal using the Ra...
SUNNYVALE, Calif., June 22, 2021 /PRNewswire/ -- Accuray (NASDAQ: ARAY) announced today that Suzanne Winter has been promoted to president, effective as of July 1, 2021.
Accuray (ARAY) introduces RayStation treatment planning support for CyberKnife Radiotherapy System and other radiation therapy devices.
SUNNYVALE, Calif., June 16, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the company's CyberKnife® M6™** and S7™** Ro...
Accuray's (ARAY) ClearRT imaging capability, which is now widely available following receipt of the CE Mark, offers better precision and accuracy in radiation therapy.
SUNNYVALE, Calif., June 10, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark certification for its ClearRT™ helical fan-beam kVCT imaging capabil...
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?
Investors continue to be optimistic about Accuray (ARAY) owing to its slew of regulatory approvals and strength in its TomoTherapy platform.
SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced it has entered into a new five-year $80 million term loan and $40 million revolving credit facility wit...
SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it has entered into privately negotiated agreements with the holders of its existing 3.75% senior ...
SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Jean-Philippe Pignol, M.D.
WILKES-BARRE, Pa. and SUNNYVALE, Calif.
ARAY, EBS, FARM, SHLX, and TPB have been added to the Zacks Rank #5 (Strong Sell) List on April 30, 2021
SUNNYVALE, Calif., April 29, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Accuray customers took the top two positions in the MArkerless Lung Target Tracking CHallenge (...
Accuray (ARAY) registers growth in Service and Product revenues during fiscal Q3.
Accuray (ARAY) delivered earnings and revenue surprises of -100.00% and 2.97%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
SUNNYVALE, Calif., April 27, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2021 ended March 31, 2021.
SUNNYVALE, Calif., April 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the innovative ClearRT™ helical fan-beam kVCT imaging* capability has now been in clinical use ...
SUNNYVALE, Calif., April 13, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2021, ended March 31, 2021, after the market clos...
SUNNYVALE, Calif., Feb. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the Cowen Annual Health Care Conference. The management team is scheduled to par...
SUNNYVALE, Calif., Feb. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott, M.D., MBA to the company's Board of Directors, effective as of Feb...
SUNNYVALE, Calif., Feb. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Confere...
Accuray announced better than expected fiscal Q2 results, with the first revenue from its China Type A license backlog. Orders remain erratic, but the backlog was up 11% yoy and stable sequentially, and...
Accuray (ARAY) registers growth in Service revenues during fiscal Q2.
Accuray Incorporated (ARAY) CEO Josh Levine on Q2 2021 Results - Earnings Call Transcript
Accuray (ARAY) delivered earnings and revenue surprises of 600.00% and 4.96%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
SUNNYVALE, Calif., Jan. 27, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2021 ended December 31, 2020. Second Quarter Fi...
One of the counterintuitive dynamics of the pandemic-disrupted year in 2020 was the rise of Wall Street. But that doesn't mean you've missed the boat, as these stocks under $10 demonstrate.
Accuray (ARAY) releases positive data from a prospective trial of 338 women with low-risk breast cancer.
SUNNYVALE, Calif., Jan. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8 per...
SUNNYVALE, Calif., Jan. 8, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2021, ended December 31, 2020, after the market cl...
Accuray (ARAY) new innovative imaging solution is designed to provide cost effective and exceptional diagnostic quality image.
SUNNYVALE, Calif., Jan. 6, 2021 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced its participation in the 39th J.P. Morgan Annual Healthcare Conference. Josh Levine, President and CEO...
SUNNYVALE, Calif., Jan. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for it...
Accuray (ARAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Investor confidence is high on Accuray (ARAY) stock, courtesy of its solid prospects.
SUNNYVALE, Calif., Dec. 3, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Jim Dennison, the company's new ...
Does Accuray (ARAY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Accuray's (ARAY) new deal with DHL Supply Chain will help in the delivery of advanced cancer treatment technology.
SUNNYVALE, Calif. and WESTERVILLE, Ohio, Nov. 18, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and DHL Supply Chain announced today they have entered into a global service parts logistics pa...
SUNNYVALE, Calif., Nov. 12, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Jim Dennison as its senior vice president of global quality and regulatory affairs, ...
SUNNYVALE, Calif., Nov. 10, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that innovations in hardware and software solutions and clinical data presented at this year's ASTRO ...
LONDON--(BUSINESS WIRE)-- #GlobalHeadandNeckCancerDiagnosticsMarket--The Head and Neck Cancer Diagnostics Market will grow by USD 3.41 bn during 2020-2024
Accuray (ARAY) registered growth in Service revenues in Q1.
Fiscal first quarter revenue was a little better than expected, and management did well on costs, achieving a modest profit where a modest loss had been expected. Orders were down, not surprising given ...
Accuray Incorporated (ARAY) CEO Josh Levine on Q1 2021 Results - Earnings Call Transcript
Accuray (ARAY) delivered earnings and revenue surprises of 100.00% and 10.82%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
About ARAY
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during ... [Read more...]
| Industry Medical Devices | IPO Date Feb 8, 2007 |
| CEO Joshua Levine | Employees 932 |
| Stock Exchange NASDAQ | Ticker Symbol ARAY |
Analyst Forecasts
According to 5 analysts, the average rating for Accuray stock is "Strong Buy." The 12-month stock price forecast is 8.25, which is an increase of 96.90% from the latest price.